← Scroll for more →
Viatris Inc (VTRS)
Pharmaceutical Preparations
Latest Price
$17.72
TTM P/E
--
Normalized P/E
--
Div Yield
2.71%
Book Value
12.25
P/B Ratio
1.45
Valuation metrics
adjust assumptions →Base FCF: $2.4B (median of recent 5yr)
Growth: -2%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$9.67
45% downside
Institutional Ownership
91.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 96.66M | $1.53B | 8.34% | +80.07M | 2026-06-30 |
| BlackRock, Inc. | 86.02M | $1.36B | 7.42% | +1.66M | 2026-06-30 |
| Vanguard Capital Management LLC | 76.05M | $1.21B | 6.56% | +1.33M | 2026-06-30 |
| Davis Selected Advisers | 75.23M | $1.19B | 6.49% | -2.98M | 2026-06-30 |
| Price T Rowe Associates Inc | 68.21M | $1.08B | 5.88% | +2.35M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 54.28M | $861.0M | 4.68% | +370.8K | 2026-06-30 |
| State Street Corp | 53.07M | $842.0M | 4.58% | +835.8K | 2026-06-30 |
| Rubric Capital Management LP | 34.17M | $542.0M | 2.95% | +668.7K | 2026-06-30 |
| Geode Capital Management, LLC | 32.81M | $520.0M | 2.83% | +961.8K | 2026-06-30 |
| Dimensional Fund Advisors LP | 29.97M | $475.0M | 2.58% | -8.34M | 2026-06-30 |